SANTA CLARA, Calif., April 24, 2023 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular disease, will report financial results for the first quarter 2023 after market close on Monday, May 8, 2023. Company management will host…Read More
Shockwave Medical Announces Details for Conference Call Discussing First Quarter 2023 Results and Participation in Upcoming Investor Conference
